Richard Gregory 4/A
4/A · Interpace Diagnostics Group, Inc. · Filed Mar 8, 2019
Insider Transaction Report
Form 4/AAmended
Richard Gregory
Chief Commercial Officer
Transactions
- Award
Common Stock
2018-12-05+13,400→ 44,641 total - Award
Stock Option (right to buy)
2018-12-05+53,600→ 53,600 totalExercise: $1.08Exp: 2028-12-05→ Common Stock (53,600 underlying)
Footnotes (4)
- [F1]On December 6, 2018, the award of restricted stock units was inadvertently omitted from the reporting person's Form 4 filing. The restricted stock units vest annually, in equal installments, over a three-year period, commencing on December 5, 2019.
- [F2]Each restricted stock unit represents the contingent right to receive one share of common stock of the Issuer.
- [F3]On December 6, 2018, the award of stock options was inadvertently overstated on the reporting person's Form 4 filing as 67,000 stock options. 53,600 stock options were awarded.
- [F4]The stock options vest and become exercisable over a three-year period, in equal installments, commencing on December 5, 2019, subject to the reporting person's continued service with the Issuer.